by The global Flow Cytometry Market is estimated to be valued at US$ 6280.32 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Flow cytometry is a technology used to analyze the physical and chemical characteristics of cells or particles. It helps detect and measure fluorescent labels attached to biomolecules within individual cells. Flow cytometry allows for the identification and counting of cell populations as well as sorting of rare cell types.
Market key trends:
The growth of the flow cytometry market is driven by technological advancements in flow cytometry platforms which have enabled high-throughput screening and early disease diagnosis. Multicolor flow cytometry allows monitoring of ten or more parameters of individual cells simultaneously. Stratification of diseases based on molecular biomarkers detected by flow cytometry helps understand disease heterogeneity and select optimal treatments. The introduction of user-friendly software and intuitive interfaces has made flow cytometry accessible to not only leading research universities and hospitals but also small medical facilities.
SWOT Analysis
Strength: Flow cytometry offers high speed and multiparameter characterization of various cells and particles. It provides quantitative and qualitative analysis of complex biological systems in real-time.
Weakness: Flow cytometry is an expensive technique which requires large upfront investments and high maintenance costs. Data analysis can be complex due to high parameter data sets.
Opportunity: Growth in stem cell research, immunology and cancer research will drive the demand for flow cytometry applications. Advancements in microfluidics and imaging technologies provide opportunities to combine flow cytometry with other techniques.
Threats: Presence of alternative technologies like western blotting, PCR and microscopy poses competition to flow cytometry market. Restriction on the use of certain lasers and reagents hampers the market growth.
Key Takeaways
The Global Flow Cytometry Market Size is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing adoption in stem cell research and immunology applications.
Regional analysis: North America dominated the global flow cytometry market and accounted for over 40% of the total share in 2023 owing to increasing R&D investments and advanced healthcare infrastructure in the region. Asia Pacific is anticipated to be the fastest growing region during the forecast period supported by growing biotechnology and pharmaceutical industries.
Key players: The key players operating in the flow cytometry market are General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma. Companies are focusing on product innovation through mergers, acquisitions and partnerships.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
